Yoshida Y - Search Results

1

Topical treatment of cutaneous herpes simplex virus-1 infection in mice with a specially formulated caffeine gel (Cafon).

Yamamura J, Koyasu M, Sato H, Kurokawa M, Yoshida Y, Amahabu Y, Shiraki K. Yamamura J, et al. Among authors: yoshida y. J Dermatol Sci. 1996 Apr;12(1):50-5. doi: 10.1016/0923-1811(95)00464-5. J Dermatol Sci. 1996. PMID: 8740461

2

Processing of hepatitis B virus surface antigen expressed by recombinant Oka varicella vaccine virus.

Shiraki K, Ochiai H, Matsui S, Aiba N, Yoshida Y, Okuno T, Yamanishi K, Takahashi M. Shiraki K, et al. Among authors: yoshida y. J Gen Virol. 1992 Jun;73 ( Pt 6):1401-7. doi: 10.1099/0022-1317-73-6-1401. J Gen Virol. 1992. PMID: 1318942

3

Prophylactic treatment of cytomegalovirus infection with traditional herbs.

Yukawa TA, Kurokawa M, Sato H, Yoshida Y, Kageyama S, Hasegawa T, Namba T, Imakita M, Hozumi T, Shiraki K. Yukawa TA, et al. Among authors: yoshida y. Antiviral Res. 1996 Oct;32(2):63-70. doi: 10.1016/0166-3542(95)00978-7. Antiviral Res. 1996. PMID: 8891165

4

Efficacy of Cafon gel on cutaneous infection with herpes simplex virus (HSV)-2 and acyclovir-resistant HSV in mice.

Yoshida Y, Yamamura J, Sato H, Koyasu M, Obara Y, Sekiguchi H, Kawana T, Shiraki K. Yoshida Y, et al. J Dermatol Sci. 1996 Dec;13(3):237-41. doi: 10.1016/s0923-1811(97)89474-1. J Dermatol Sci. 1996. PMID: 9023706

5

Augmentation of natural killer cell activity induced by cytomegalovirus infection in mice treated with FK506.

Kageyama S, Matsui S, Hasegawa T, Yoshida Y, Sato H, Yamamura J, Kurokawa M, Yamamoto H, Shiraki K. Kageyama S, et al. Among authors: yoshida y. Acta Virol. 1997 Aug;41(4):215-20. Acta Virol. 1997. PMID: 9391652

6

A live non-neurovirulent herpes simplex virus vector expresses beta-galactosidase in the nervous system of the Wistar and Sprague-Dawley strain rat for a prolonged period.

Shiraki K, Yamamura J, Kurokawa M, Andoh T, Sato H, Yoshida Y, Li ZH, Kamiyama T, Kageyama S. Shiraki K, et al. Among authors: yoshida y. Neurosci Lett. 1998 Apr 3;245(2):69-72. doi: 10.1016/s0304-3940(98)00183-9. Neurosci Lett. 1998. PMID: 9605487

7

Construction of Oka varicella vaccine expressing human immunodeficiency virus env antigen.

Shiraki K, Sato H, Yoshida Y, Yamamura JI, Tsurita M, Kurokawa M, Kageyama S. Shiraki K, et al. Among authors: yoshida y. J Med Virol. 2001 Jun;64(2):89-95. doi: 10.1002/jmv.1022. J Med Virol. 2001. PMID: 11360239

8

Interleukin 12 is a primary cytokine responding to influenza virus infection in the respiratory tract of mice.

Hama Y, Kurokawa M, Imakita M, Yoshida Y, Shimizu T, Watanabe W, Shiraki K. Hama Y, et al. Among authors: yoshida y. Acta Virol. 2009;53(4):233-40. doi: 10.4149/av_2009_04_233. Acta Virol. 2009. PMID: 19941386

9

[Clinical aspect of temporal lobe contusion].

Togo M, Yoshida Y, Sato H, Yamashita J, Mori K. Togo M, et al. Among authors: yoshida y. Geka Chiryo. 1971 Oct;25(4):371-7. Geka Chiryo. 1971. PMID: 5172141 Japanese. No abstract available.

10

[Acute extradural hematoma of the posterior fossa. Diagnostic value of vertebral angiography].

Yamashita J, Mori K, Sato H, Yoshida Y, Fukumitsu T. Yamashita J, et al. Among authors: yoshida y. No To Shinkei. 1970 Mar;22(3):277-82. No To Shinkei. 1970. PMID: 5467575 Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,033 results

Search Page

Filters